119 related articles for article (PubMed ID: 18443252)
1. Considering competing risks . . . Not all black and white.
Cauley JA; Ensrud KE
Arch Intern Med; 2008 Apr; 168(8):793-5. PubMed ID: 18443252
[No Abstract] [Full Text] [Related]
2. [Osteoporosis and bisphosphonates].
Zuber MA
Z Rheumatol; 2007 Dec; 66(8):713-5. PubMed ID: 17955251
[No Abstract] [Full Text] [Related]
3. [Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].
Ringe JD
MMW Fortschr Med; 2009 Mar; 151(10):7. PubMed ID: 19472655
[No Abstract] [Full Text] [Related]
4. Alendronate and atrial fibrillation.
Cummings SR; Schwartz AV; Black DM
N Engl J Med; 2007 May; 356(18):1895-6. PubMed ID: 17476024
[No Abstract] [Full Text] [Related]
5. [Thiazolidinediones and skeletal health].
Meier C; Bodmer M; Meier CR; Kraenzlin ME
Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930
[TBL] [Abstract][Full Text] [Related]
6. Alendronate, osteoporosis, and atherosclerosis.
Strandberg TE
Arch Intern Med; 2008 Nov; 168(21):2386-7; author reply 2387. PubMed ID: 19029508
[No Abstract] [Full Text] [Related]
7. Use of alendronate and risk of incident atrial fibrillation in women.
Heckbert SR; Li G; Cummings SR; Smith NL; Psaty BM
Arch Intern Med; 2008 Apr; 168(8):826-31. PubMed ID: 18443257
[TBL] [Abstract][Full Text] [Related]
8. What's the story with Fosamax? Recent reports have women wondering if they should stop taking this widely prescribed osteoporosis drug.
Harv Womens Health Watch; 2008 Nov; 16(3):1-2. PubMed ID: 19043857
[No Abstract] [Full Text] [Related]
9. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
Bize R; Lamy O; Peytremann-Bridevaux I
Rev Med Suisse; 2008 Dec; 4(183):2703. PubMed ID: 19157286
[No Abstract] [Full Text] [Related]
10. Diabetes drug pioglitazone (Actos): risk of fracture.
Meymeh RH; Wooltorton E
CMAJ; 2007 Sep; 177(7):723-4. PubMed ID: 17823139
[No Abstract] [Full Text] [Related]
11. Study confirms link between certain diabetes drugs and fractures.
Harv Womens Health Watch; 2010 May; 17(9):6. PubMed ID: 20593558
[No Abstract] [Full Text] [Related]
12. Fracture risk is a class effect of glitazones.
Short R
BMJ; 2007 Mar; 334(7593):551. PubMed ID: 17363794
[No Abstract] [Full Text] [Related]
13. Ask the doctor. I am 86 years old and have been taking Fosamax to strengthen my bones for nearly 10 years. A few months ago, I suddenly fainted and was later diagnosed with atrial fibrillation. Did that happen because I was taking Fosamax?
Lee T
Harv Heart Lett; 2007 Oct; 18(2):8. PubMed ID: 18232110
[No Abstract] [Full Text] [Related]
14. Alendronate-induced asthma.
Isik A; Uras I; Uyar ME; Karakurt F; Kaftan O
Ann Pharmacother; 2009 Mar; 43(3):547-8. PubMed ID: 19261958
[No Abstract] [Full Text] [Related]
15. Thiazolidinedione-induced skeletal fragility--mechanisms and implications.
Grey A
Diabetes Obes Metab; 2009 Apr; 11(4):275-84. PubMed ID: 18671797
[TBL] [Abstract][Full Text] [Related]
16. Adverse cutaneous drug reaction to alendronate.
Brinkmeier T; Kügler K; Lepoittevin JP; Frosch PJ
Contact Dermatitis; 2007 Aug; 57(2):123-5. PubMed ID: 17627657
[No Abstract] [Full Text] [Related]
17. Alendronate-induced synovitis.
Gwynne Jones DP; Savage RL; Highton J
J Rheumatol; 2008 Mar; 35(3):537-8. PubMed ID: 18203307
[TBL] [Abstract][Full Text] [Related]
18. An esophageal ulcer mimicking advanced esophageal cancer in a patient on alendronate sodium treatment for osteoporosis.
Terashima T; Hiramatsu K; Shimatani A; Matsuda M; Ogino H; Satomura Y; Noda Y
Endoscopy; 2006; 38 Suppl 2():E37. PubMed ID: 17366400
[No Abstract] [Full Text] [Related]
19. Bisphosphonates and the risk of atrial fibrillation.
Sewerynek E; Stuss M
Endokrynol Pol; 2011; 62(1):93-6. PubMed ID: 21365587
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates and atrial fibrillation.
Prescrire Int; 2008 Aug; 17(96):161. PubMed ID: 19492493
[No Abstract] [Full Text] [Related]
[Next] [New Search]
